Alaunos Therapeutics Inc. (NASDAQ: TCRT)
$0.65
+0.0010 ( +0.15% ) 44.7K
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations.
Market Data
Open
$0.65
Previous close
$0.65
Volume
44.7K
Market cap
$10.86M
Day range
$0.63 - $0.67
52 week range
$0.56 - $7.50
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 12 | Jan 02, 2024 |
| 8-k | 8K-related | 12 | Dec 28, 2023 |
| 8-k | 8K-related | 12 | Dec 22, 2023 |
| 8-k | 8K-related | 13 | Nov 15, 2023 |
| 10-q | Quarterly Reports | 64 | Nov 14, 2023 |
| 8-k | 8K-related | 15 | Nov 14, 2023 |
| 8-k | 8K-related | 12 | Sep 28, 2023 |
| 4 | Insider transactions | 1 | Sep 05, 2023 |
| 8-k | 8K-related | 14 | Aug 14, 2023 |
| 10-q | Quarterly Reports | 58 | Aug 14, 2023 |